酒精使用与心血管疾病:美国心脏协会科学声明
该科学声明指出,每日不超过1至2杯低量饮酒对冠心病、卒中、猝死及可能的心力衰竭无风险或可能降低风险,但与心房颤动的风险关联未知;而暴饮或日均≥3杯的重度饮酒与所有研究的心血管疾病结局恶化一致相关。因多数证据为观察性研究,临床应强化运动、戒烟和维持健康体重等健康生活方式。
要点
- 每日≤1至2杯低量饮酒对冠心病、卒中、猝死及可能心衰无风险或可能降低风险。
- 低量饮酒与心房颤动的风险关联仍未知。
- 暴饮或日均≥3杯重度饮酒与所有心血管疾病结局恶化一致相关。
核心结论
- 低量饮酒(如每日不超过1至2杯)对冠心病、卒中、猝死及可能的心力衰竭无风险或可能降低风险。
- 低量饮酒(每日1至2杯)与心房颤动的风险关联仍未知。
- 重度饮酒如暴饮或日均≥3杯与所有研究的心血管疾病结局恶化一致相关。
- 因证据水平限制,饮酒是否属于健康生活方式仍未知。
研究设计与样本
- 美国心脏协会科学声明,基于现有研究证据总结。
- 多数研究为观察性研究,易受偏倚和混杂影响。
主要发现
- 低量饮酒(每日不超过1至2杯)对冠心病、卒中、猝死及可能的心力衰竭无风险或可能降低风险。
- 每日1至2杯饮酒与心房颤动的风险关联未知。
- 暴饮或日均≥3杯饮酒与所有研究的心血管疾病结局恶化一致相关。
- 需要更多低至中度饮酒的随机试验以得出更明确结论。
临床怎么用
- 临床医生应强化健康生活方式行为,如定期进行体力活动、避免烟草使用和维持健康体重。
- 鉴于证据水平,饮酒是否属于健康生活方式仍未知,临床不应据此推荐饮酒。
局限性
- 多数研究为观察性,易受偏倚和混杂影响。
- 需要更多低至中度饮酒的随机试验以得出更明确结论。
- 低量饮酒与心房颤动的风险关联仍未知。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Alcohol is one of the most commonly consumed substances in the world, exhibiting complex relationships with multiple aspects of cardiovascular health and disease. The majority of the research on the topic is observational and therefore prone to bias and confounding. The available evidence suggests no risk to possible risk reduction when alcohol is consumed in low amounts (such as no more than 1 to 2 drinks a day) in regard to coronary artery disease, stroke, sudden death, and possibly heart failure. The risk associated with consuming 1 to 2 drinks a day on atrial fibrillation remains unknown. More randomized trials of low to moderate alcohol consumption are needed for more definitive conclusions. In stark contrast, heavier alcohol consumption such as binge drinking or consuming on average ≥3 drinks a day is consistently associated with worse outcomes in every cardiovascular disease entity studied. Considering the level of evidence, it remains unknown whether drinking is part of a healthy lifestyle and therefore clinicians should reinforce healthy lifestyle behaviors such as regularly engaging in physical activity, avoiding tobacco use, and maintaining healthy body weight.
引用
- Piano MR, Marcus GM, Aycock DM, et al. Alcohol Use and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2025. PMID: 40485439. doi:10.1161/CIR.0000000000001341
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。